Transamerica Financial Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Transamerica Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $692 - $844	-1 Reduced 25.0%	3 $3,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $705 - $766	-1 Reduced 20.0%	4 $3,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $2,741 - $3,694	5 New	5 $2,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $574 - $680	-1 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $472 - $558	1 New	1 $1,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.